Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKinsey
Moodys
Johnson and Johnson
Express Scripts

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

CARNEXIV Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Carnexiv, and what generic alternatives are available?

Carnexiv is a drug marketed by Lundbeck Pharms Llc and is included in one NDA. There are six patents protecting this drug.

This drug has seventy-two patent family members in twenty-one countries.

The generic ingredient in CARNEXIV is carbamazepine. There are twenty-seven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.

US ANDA Litigation and Generic Entry Outlook for Carnexiv

A generic version of CARNEXIV was approved as carbamazepine by TARO on October 3rd, 1996.

  Start Trial

Drug patent expirations by year for CARNEXIV
Recent Litigation for CARNEXIV

Identify potential future generic entrants

District Court Litigation
Case NameDate
CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA2019-05-23
MERCK SHARP & DOHME CORP. v. MYLAN LABORATORIES LIMITED2018-03-29
CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.2017-12-20

See all CARNEXIV litigation

PTAB Litigation
PetitionerDate
2014-12-29
2014-07-03

See all CARNEXIV litigation

Synonyms for CARNEXIV
(z)-5h-dibenzo[b,f]azepine-5-carboxamide
11-benzo[b][1]benzazepinecarboxamide
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
298-46-4
33CM23913M
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5-Carbomoyl-5H-dibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acid
5H-Dibenz(b,f)azepine-5-carboxamide maleic acid
5H-Dibenz(b,f)azepine-5-carboxamide oxalic acid
5H-Dibenz[ b, f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5-carboxamine
5H-Dibenzo[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide #
5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A
5H-dibenzo[b,f]azepine-5-carboximidic acid
A820074
AB00051931_19
AB00051931_20
AB00051931-17
AB00051931-18
AB0070254
AB1009530
AC-9538
ACT02606
AK116064
AKOS003235644
AKOS025397243
Amizepin
Amizepine
AOB5783
Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt
BBL005372
BCP21380
BDBM50003659
benzo[b][1]benzazepine-11-carboxamide
BG0497
BIDD:GT0479
BIM-0050280.0001
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C-13993
C06868
Calepsin
Carbamazepen
Carbamazepin
Carbamazepin 100 microg/mL in Methanol
Carbamazepina
Carbamazepina [INN-Spanish]
carbamazepine
Carbamazepine (Carbatrol)
Carbamazepine (JP17/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine [USAN:USP:INN:BAN:JAN]
Carbamazepine 1.0 mg/ml in Methanol
carbamazepine host structure with 4-hydroxybenzoic acid removed
carbamazepine host structure with DL-tartaric acid removed
carbamazepine host structure with maleic acid removed
carbamazepine host structure with oxalic acid removed
Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Carbamazepine, 98%
Carbamazepine, analytical standard
Carbamazepine, British Pharmacopoeia (BP) Reference Standard
Carbamazepine, European Pharmacopoeia (EP) Reference Standard
Carbamazepine, meets USP testing specifications
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
Carbamazepine, powder
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
Carbamazepine(Carbatrol)
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
CAS-298-46-4
CBChromo1_000350
CBZ
CBZ;NSC 169864
CC-25382
CC-25383
CCG-38931
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CPD001227191
CS-2225
D00252
DB-047659
DB00564
dibenzo[b,f]azepine-5-carboxamide
Dibenzo[b,f]azepine-5-carboxylic acid amide
Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)
DivK1c_000388
DivK1c_003750
DSSTox_CID_2731
DSSTox_GSID_22731
DSSTox_RID_76704
DTXSID4022731
EINECS 206-062-7
EN300-21678
Epitol
Epitope ID:174842
Equetro
Equetro (TN)
EU-0100292
F0348-2551
FFGPTBGBLSHEPO-UHFFFAOYSA-N
Finlepsin
FT-0602927
FT-0696814
G 32883
G-32883
Geigy 32883
GP8250
GTPL5339
H2605
H495
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS2095K05
HMS2233G16
HMS3039K09
HMS3259B21
HMS3260L06
HMS3372J13
HMS3657G03
HMS3712K05
HMS3747E03
HMS501D10
HMS640O02
HSDB 3019
HY-B0246
IDI1_000388
IMED104589831
Iminostilbene-N-carboxamide
Karbamazepin
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
KS-00000KI8
KS-5146
Lexin
Lopac-C-4024
Lopac0_000292
LP00292
LS-60362
MCULE-9121567287
MFCD00005073
MLS000069652
MLS001055475
MLS001074172
MLS002548877
N6W
NC00679
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-04
NCGC00015234-05
NCGC00015234-06
NCGC00015234-07
NCGC00015234-08
NCGC00015234-09
NCGC00015234-10
NCGC00015234-11
NCGC00015234-12
NCGC00015234-13
NCGC00015234-14
NCGC00015234-15
NCGC00015234-16
NCGC00015234-19
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NCGC00253982-01
NCGC00259822-01
NCGC00260977-01
Neurotol
Neurotop retard
NINDS_000388
NSC 169864
NSC-169864
NSC-755920
NSC169864
NSC755920
Opera_ID_72
Oprea1_790775
Pharmakon1600-01500159
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Q-200792
Q410412
s1693
SAM002264603
SBI-0050280.P004
SC-16243
SCHEMBL19838283
SCHEMBL21639
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
SR-01000000229
SR-01000000229-2
SR-01000000229-4
SR-01000000229-7
ST075773
ST2418853
Stazepin
Stazepine
STK177357
STL453548
SW220141-1
SY002823
Tegretal
Tegretol
Tegretol (TN)
Tegretol Cr
Tegretol-Xr
Tegretol,Carbamazepine
Telesmin
Teril
Timonil
Tox21_110104
Tox21_110104_1
Tox21_202273
Tox21_300195
Tox21_500292
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
Z2199879032
ZINC4785

US Patents and Regulatory Information for CARNEXIV

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No   Start Trial   Start Trial   Start Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKinsey
Moodys
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.